These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8851651)

  • 1. Venlafaxine in social phobia.
    Kelsey JE
    Psychopharmacol Bull; 1995; 31(4):767-71. PubMed ID: 8851651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine.
    Allgulander C; Mangano R; Zhang J; Dahl AA; Lepola U; Sjödin I; Emilien G;
    Hum Psychopharmacol; 2004 Aug; 19(6):387-96. PubMed ID: 15303242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venlafaxine in the treatment of borderline personality disorder.
    Markovitz PJ; Wagner SC
    Psychopharmacol Bull; 1995; 31(4):773-7. PubMed ID: 8851652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
    Hedges D; Reimherr FW; Rogers A; Strong R; Wender PH
    Psychopharmacol Bull; 1995; 31(4):779-83. PubMed ID: 8851653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
    Pollack MH; Worthington JJ; Otto MW; Maki KM; Smoller JW; Manfro GG; Rudolph R; Rosenbaum JF
    Psychopharmacol Bull; 1996; 32(4):667-70. PubMed ID: 8993089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nefazodone for social phobia: a clinical case series.
    Worthington JJ; Zucker BG; Fones CS; Otto MW; Pollack MH
    Depress Anxiety; 1998; 8(3):131-3. PubMed ID: 9836065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone in social phobia.
    Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label trial of venlafaxine in adults with attention deficit disorder.
    Adler LA; Resnick S; Kunz M; Devinsky O
    Psychopharmacol Bull; 1995; 31(4):785-8. PubMed ID: 8851654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
    Gründer G; Wetzel H; Schlösser R; Benkert O
    Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.
    March JS; Entusah AR; Rynn M; Albano AM; Tourian KA
    Biol Psychiatry; 2007 Nov; 62(10):1149-54. PubMed ID: 17553467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine XR in the treatment of anxiety.
    Hackett D
    Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial.
    van Kerkhoven LA; Laheij RJ; Aparicio N; De Boer WA; Van den Hazel S; Tan AC; Witteman BJ; Jansen JB
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):746-52; quiz 718. PubMed ID: 18424191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose venlafaxine treatment in panic disorder.
    Papp LA; Sinha SS; Martinez JM; Coplan JD; Amchin J; Gorman JM
    Psychopharmacol Bull; 1998; 34(2):207-9. PubMed ID: 9641002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
    Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.